Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Clostridia as agents of zoonotic disease.
Concepts for regulation of axon integrity by enwrapping glia.
The Hygiene Theory Harnessing Helminths and Their Ova to Treat Autoimmunity.
Eriocalyxin B ameliorates experimental autoimmune encephalomyelitis by suppressing Th1 and Th17 cells.
Sphingolipids in neuroinflammation.
Protective Role of (RS )-glucoraphanin Bioactivated with Myrosinase in an Experimental Model of Multiple Sclerosis.
The effect of disease modifying therapies on brain atrophy in patients with relapsing-remitting multiple sclerosis: a systematic review and meta-analysis.
Abnormal NMDA receptor function exacerbates experimental autoimmune encephalomyelitis.
Multiple sclerosis and co-morbid autoimmune disease: the final nail in the coffin?
Microcystic macular oedema, thickness of the inner nuclear layer of the retina, and disease characteristics in multiple sclerosis: a retrospective study.
Multiple sclerosis.
Novel oxazolo-oxazole derivatives of FTY720 reduce endothelial cell permeability, immune cell chemotaxis and symptoms of experimental autoimmune encephalomyelitis in mice.
Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.
Mind-body medicine for multiple sclerosis: a systematic review.
From genes to characteristics of multiple sclerosis.
Magnetic susceptibility anisotropy: Cylindrical symmetry from macroscopically ordered anisotropic molecules and accuracy of MRI measurements using few orientations.
Frequent early multiple sclerosis relapses during treatment with fingolimod: a paradoxical effect?
Induction of multiple sclerosis and response to tyrosine kinase inhibitors.
Central Nervous System Idiopathic Inflammatory Demyelinating Disorders in South Americans: A Descriptive, Multicenter, Cross-Sectional Study.
Fingolimod Treatment in Relapsing-Remitting Multiple Sclerosis Patients: A Prospective Observational Multicenter Postmarketing Study.
Selective inhibition by riluzole of voltage-dependent sodium channels and catecholamine secretion in adrenal chromaffin cells.
Unfavorable outcomes during treatment of multiple sclerosis with high doses of vitamin D.
Preventing brain atrophy should be the gold standard of effective therapy in multiple sclerosis (after the first year of treatment): Commentary.
Atorvastatin: Multiple Sclerosis.
Relationships among physical inactivity, deconditioning, and walking impairment in persons with multiple sclerosis.

Pages